Biogen Inc (BIIB)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 21.24B
P/E Ratio
13.87
Revenue (TTM)
$ 10B
Volume
0
52W High
$ 204.18
52W Low
$ 110.04
Dividend Yield
0.00%
Beta
0.11
Technicals
50-Day MA
134.2148
200-Day MA
136.3478
52 Week High
204.18
52 Week Low
110.04
About BIIB
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
Employees
7605
Headquarters
Cambridge, MA
CEO
Mr. Christopher A. Viehbacher
Latest News
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
22.95
Percentile: 33.82
Environmental Risk Score
1.02
Percentile: 2
Social Risk Score
13.48
Percentile: 2
Governance Risk Score
7.45
Percentile: 2
Controversy Level
ESG data provided by Sustainalytics, Inc.
BIIB
Category Average
2Moderate Controversy Level
NoneSevere